VAXX (OTC)
VAXXINITY INC A
$0.000100
+0.000000 (+0.00%)
Prev close: $0.000100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mei Mei Hu
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.01M
- Employees
- 57
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-0.10 | $-0.12 | +0.0224 | +18.30% |
|
Jun 2023 (Q2)
|
$-0.11 | $-0.16 | +0.0481 | +30.42% |
|
Mar 2023 (Q1)
|
$-0.15 | $-0.16 | +0.0132 | +8.09% |
|
Dec 2022 (Q4)
|
$-0.16 | $-0.16 | +0.0032 | +1.96% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $58.29M |
| Research and Development | $35.90M |
| Other Operating Expenses | $22.39M |
| Operating Income/Loss | -$58.29M |
| Income/Loss From Continuing Operations After Tax | -$56.93M |
| Income/Loss From Continuing Operations Before Tax | -$56.93M |
| Interest Expense, Operating | $696.00K |
| Net Income/Loss | -$56.93M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$56.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$56.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.45 |
| Diluted Earnings Per Share | -$0.45 |
| Basic Average Shares | 126,508,917 |
| Diluted Average Shares | 126,508,917 |
| Assets | $44.31M |
| Current Assets | $33.23M |
| Prepaid Expenses | $2.32M |
| Other Current Assets | $30.91M |
| Noncurrent Assets | $11.08M |
| Fixed Assets | $11.08M |
| Liabilities | $30.90M |
| Current Liabilities | $17.61M |
| Wages | $1.56M |
| Other Current Liabilities | $16.05M |
| Noncurrent Liabilities | $13.30M |
| Equity | $13.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.41M |
| Liabilities And Equity | $44.31M |
| Net Cash Flow From Operating Activities | -$57.24M |
| Net Cash Flow From Operating Activities, Continuing | -$57.24M |
| Net Cash Flow From Investing Activities | $28.84M |
| Net Cash Flow From Investing Activities, Continuing | $28.84M |
| Net Cash Flow From Financing Activities | -$1.14M |
| Net Cash Flow From Financing Activities, Continuing | -$1.14M |
| Net Cash Flow | -$29.53M |
| Net Cash Flow, Continuing | -$29.53M |
| Comprehensive Income/Loss | -$56.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$56.73M |
| Other Comprehensive Income/Loss | -$56.73M |